Skip to search formSkip to main contentSkip to account menu

S 596

Known as: S-596 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
The effects of S-596 and coarteolol, new beta-adrenergic blockers, were studied by means of the oral fluorescein method. Transfer… 
1985
1985
Binding characteristics of the β-antagonists and agonists with the β-adrenoceptors were investigated in [3H] dihydroalprenolol… 
1985
1985
The effects of d1-2-(3'-t-butylamino-2'-hydroxypropylthio)-4-(5'-carbamoyl-2'-thi enyl) thiazole hydrochloride (S-596) were… 
1985
1985
The mechanism of the hypotensive effect of arotinolol (dl-2-(3'-t-butylamino-2'-hydroxypropylthio)-4-(5'-carbamoyl-2'-th ienyl… 
1983
1983
The effects of a therapeutic dose of oral S-596 upon the cardiovascular response to intravenous isoproterenol and noradrenaline… 
1983
1983
The effects of the new beta-adrenoceptor blocking agent, S-596, on the peripheral autonomic nervous system and smooth muscles… 
1983
1983
Effects of a new adrenergic beta-blocking agent, arotinolol (S-596), on the blood pressure and heart rate were assessed in… 
1983
1983
Effects of S-596 on dog coronary arteries were investigated in vitro. S-596 produced concentration-dependent relaxations of… 
1979
1979
We developed a new beta-adrenergic blocking, antiarrhythmic compound S-596 and compared the findings with those of propranolol or…